![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 47, 33179-33182, November 19, 1999
From the Department of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas 75235-9040
The actin cytoskeleton is an essential scaffold
for integrating membrane and intracellular functions. It is very
dynamic and is remodeled in response to a variety of signals. Growth
factor stimulation promotes actin assembly at the plasma membrane to generate movement, whereas apoptotic signals cause cytoskeletal destruction to elicit characteristic membrane blebbing and
morphological changes. Gelsolin is a Ca2+- and
polyphosphoinositide 4,5-bisphosphate
(PIP2)1-regulated
actin filament severing and capping protein that is implicated in actin
remodeling in growing and in apoptotic cells (reviewed in Refs. 1 and
2).
This review summarizes data supporting the role of gelsolin in
cytoskeletal remodeling and phosphoinositide signaling and discusses
the structural basis for the Ca2+ and PIP2
regulation of severing and capping by gelsolin.
Gelsolin is the most potent actin filament severing protein
identified to date. Severing is the weakening of enough non-covalent bonds between actin molecules within a filament to break the filament in two. Gelsolin severs stoichiometrically and with close to 100% efficiency (3). Severing is initiated after gelsolin binds to the side
of an actin filament. Gelsolin binds filaments rapidly but severs
slowly (3); the delay may reflect the time required for structural
rearrangement within gelsolin (see "Structural Basis for
Ca2+ Regulation") and in the filament (4) prior to
severing. Gelsolin changes actin conformation and kinks the actin
filament (4), suggesting a mechanical basis for severing.
After severing, gelsolin remains attached to the barbed end of the
filament as a cap. As a result, short actin filaments that cannot
reanneal with each other or elongate at their barbed ends are
generated. In this way, the actin network is disassembled. The
importance of Ca2+-mediated actin severing has been clearly
documented during platelet activation (5), and gelsolin is the only
known Ca2+-dependent severing protein
identified to date. Gelsolin severing can also have a constructive
effect because it increases the number of filaments. Uncapping of
gelsolin from these filaments generates many polymerization-competent
ends from which actin can grow to rebuild the cytoskeleton to new
specifications. Therefore, gelsolin can promote actin polymerization by
severing followed by uncapping (mechanism B, as discussed in the
Prologue (74) of this series).
The Gelsolin Null Mouse Establishes the Importance of Gelsolin for
Multiple Cell Functions--
Cells from gelsolin null mice exhibit a
variety of motility and actin defects. Gelsolin null fibroblasts have
pronounced actin stress fibers (6), and this phenotype is consistent
with an inability to sever and remodel actin filaments. They do not
ruffle in response to growth factor (7), and they exhibit defective chemotaxis and wound healing. The rate of clotting is reduced (6), as
would be consistent with the requirement of actin severing for platelet
activation (5). Neurite retraction is defective (8), and neurons are
more susceptible to glutamate-induced excito-toxicity (9). Neutrophil
extravasation is compromised (6). These findings establish the
importance of gelsolin in maintaining motility and actin dynamics.
Despite multiple cellular pathology, the null animals (in a mixed
strain background) are without gross phenotypic defects. This may
reflect the existence of potent compensatory mechanisms. However, the
compensation is incomplete and varies with the genetic background of
the knockout animals. Gelsolin null animals in a pure strain mouse
background are non-viable at perinatal and early postnatal stages (2),
indicating that gelsolin is necessary for survival.
Membrane ruffling is a functional readout for a coordinated series of
membrane and cytoskeletal events, and it is activated by the small
GTPase, Rac. Gelsolin null fibroblasts have increased Rac expression
(7), and Rac·GTP dissociates gelsolin-actin complexes (equivalent to
uncapping) in cell extracts but not purified gelsolin-actin complexes
(10). These results suggest that gelsolin is a downstream effector of
Rac, but there are additional steps between Rac and gelsolin
activation/inactivation. A number of studies suggest that linkage
through the type I phosphatidylinositol 5-kinases (PIP5KIs), the major
enzymes that synthesize PIP2 (reviewed in Refs. 11 and 12),
is an attractive possibility.
The Role of PIP2 in the Regulation of Cell
Motility--
PIP5KIs coimmunoprecipitate with Rac (13) and also Rho
(14), a small GTPase that promotes stress fiber formation. PIP5KIs may
thus be incorporated into signaling complexes that are targeted to the
plasma membrane through Rac·GTP or Rho·GTP. This increases the
local concentration of PIP2 in membrane microdomains to
selectively activate downstream cascades (reviewed in Refs. 12 and
15).
PIP2 has a pivotal role in the phosphoinositide cycle that
drives signaling, cytoskeletal organization, and membrane trafficking (reviewed in Ref. 15). Numerous cytoskeletal proteins are affected by
PIP2 in vitro. They include gelsolin family
proteins (16), profilin (17), capping protein (18), ADF/cofilin (19),
PIP2 involvement in cytoskeletal regulation is supported by
experiments that manipulate PIP2 content in intact cells
and in cell-free models. Microinjection of a monoclonal antibody to
PIP2 prevents stress fiber and focal adhesion formation
(21). PIP5KI overexpression induces the formation of short actin
bundles (27) and increases the movement of dynamic actin spots
containing a number of actin regulatory proteins (28). In contrast,
overexpression of synaptojanin, the inositol polyphosphate
5-phosphatase that dephosphorylates PIP2, reduces actin
stress fibers (29). Moreover, Hartwig et al. (30) were able
to reconstitute the entire pathway between thrombin stimulation, Rac
activation, PIP2 synthesis, and barbed end nucleated actin
assembly in permeabilized platelets. However, in neutrophils and other
systems, the relation is less clear. Although Rac·GTP dissociates
gelsolin-actin complexes (10) and stimulates PIP2
synthesis, it does not promote actin assembly in lysates (31). Instead,
Cdc42, which stimulates filopodia formation in cells, promotes de
novo actin assembly in vitro, in a
PIP2-dependent manner that is mediated through
WASp and the Arp2/3 complex (32).
The range of responses and the contradictory effects of small GTPases
and PIP2 on nucleated actin assembly in vivo and
in vitro and in different types of cells may be reconciled
by postulating that there are multiple pathways for actin assembly.
Plasma membrane lysis may disrupt the critical coupling between Rac and
actin polymerization much more than that between Cdc42 and actin.
Effects of Gelsolin Overexpression on Cell Motility and
Signaling--
Gelsolin overexpression increases membrane ruffling and
chemotaxis (33, 34), consistent with the role of gelsolin in dynamic actin remodeling. Surprisingly, CapG, a gelsolin relative that caps but
does not sever actin, and the completely unrelated capping protein also
increase cell motility when overexpressed (35, 36). A
priori, pure capping proteins are expected to be less effective in
promoting actin dynamics than severing/capping proteins, because they
do not increase the number of actin filaments per se
(compare mechanisms B (severing and uncapping) and C (uncapping only)
in the Prologue to this minireview series (74)).
These results indicate that capping/uncapping may be sufficient to
increase actin dynamics. More detailed study will be required to
distinguish between the contributions of severing and capping.
Overexpression studies reveal that gelsolin may have other roles in
addition to direct cytoskeletal regulation. Overexpressed gelsolin (34)
and CapG (35) modulate phospholipase C
In conclusion, these results suggest that as PIP2 content
and availability change during signaling, cross-talk between
PIP2-regulated proteins provides a selective mechanism for
positive as well as negative regulation of phosphoinositide signaling.
This is particularly relevant as more PIP2-regulated
proteins are identified. Gelsolin coimmunoprecipitates with several
PIP2-interacting proteins, and it alters the activity of
phosphatidylinositol 3-kinase and phospholipase D as well (reviewed in
Refs. 1 and 2). Gelsolin is phosphorylated by c-Src in
vitro, and phosphorylation is enhanced by PIP2 (38). The physiological significance of these associations and
phosphorylation has not been determined.
Gelsolin and Apoptosis--
Gelsolin is a substrate for caspase-3
(39, 40), the effector caspase in both the death receptor and
mitochondrial apoptotic pathways. Gelsolin cleaved by caspase-3 no
longer requires Ca2+ to sever actin filaments (Fig.
1) (see also "Structural Basis for
Ca2+ Regulation"), and it dismantles the membrane
cytoskeleton to cause blebbing, a hallmark of apoptosis. Overexpression
of the Ca2+-independent severing N-half induces apoptosis,
whereas gelsolin null neutrophils have a delayed onset of apoptosis
(39). These findings highlight the importance of inhibiting gelsolin
severing to preserve the integrity of the cell and to selectively
activate gelsolin under proliferative conditions.
The pro-apoptotic role of gelsolin is supported by the finding that
most cancer cells (which usually have reduced apoptosis) have
significantly lower gelsolin expression (41) (reviewed in Ref. 2).
Furthermore, gelsolin overexpression, especially of a mutant form that
is more sensitive to PIP2, suppresses Ras transformation
(42). Nevertheless, other data do not fit into this straightforward
scheme. One group found that gelsolin overexpression protects against
apoptosis (39). The relation between gelsolin, apoptosis, and
tumorigenesis probably reflects a complex balance between the multiple
effector functions of gelsolin.
The structural basis for gelsolin regulation by Ca2+
is now beginning to be understood. Gelsolin has two tandem homologous
halves, each of which contains a 3-fold segmental repeat (segments
S1-S3 and S4-S6, respectively) (43, 44) (Fig. 1). The N- and C-halves are connected by a long linker, which is cleaved by caspase-3 (39, 40)
in vivo and in vitro, and by many other proteases in vitro. The isolated C-half binds a single actin molecule
only when Ca2+ is above 10 There are two published high resolution structures of gelsolin, and a
third is on its way. We will discuss results from the first two
structures here and review results from the third structure later under
"Structural Basis for Ca2+ Regulation." The
S1-actin-Ca2+ structure (46) shows how a single gelsolin
segment binds actin. Because of the similarities between segments (43,
44), it can be used as a template for modeling how the other segments bind actin. The full-length gelsolin crystal formed in the absence of
Ca2+ (gelsolin/EGTA) shows that inactive gelsolin has a
compact quarternary structure in the absence of Ca2+ (44).
Its two halves are held together by a C-terminal S6 tail, which latches
onto S2 (Figs. 1 and 2A) (the
tail latch, see "Structural Basis for Ca2+ Regulation."
Within each half, the first and third segments (S1 and S3, S4 and S6,
respectively, for the N- and C-halves) are joined into a 10-strand
![]()
INTRODUCTION
TOP
INTRODUCTION
Overview about Severing,...
Gelsolin Functions in Vivo
Gelsolin Structure-Function
The Gelsolin Superfamily
Conclusions and Perspectives
REFERENCES
![]()
Overview about Severing, Capping, and Uncapping
TOP
INTRODUCTION
Overview about Severing,...
Gelsolin Functions in Vivo
Gelsolin Structure-Function
The Gelsolin Superfamily
Conclusions and Perspectives
REFERENCES
![]()
Gelsolin Functions in Vivo
TOP
INTRODUCTION
Overview about Severing,...
Gelsolin Functions in Vivo
Gelsolin Structure-Function
The Gelsolin Superfamily
Conclusions and Perspectives
REFERENCES
-actinin (20), vinculin (21), ezrin/radixin/moesin (22), and WASp family proteins (23). The latter four proteins are activated by
PIP2, whereas the first four are inactivated by
PIP2. Ezrin/radixin/moesin, ADF/cofilin, and WASp are
reviewed in this series (24-26). The challenge will be to identify
cytoskeletal proteins that are physiologically regulated by
PIP2 and determine how they are differentially regulated.
and phospholipase C
activity in a biphasic manner both in vivo and in
vitro. These effects depend on PIP2 binding (34),
suggesting that gelsolin enhances or competes with other
PIP2-binding proteins for their common substrate. This
potent effect may be achieved by altering the packing of
PIP2 molecules within the membrane bilayer (37).

View larger version (14K):
[in a new window]
Fig. 1.
Gelsolin structure-function domains.
Residues are numbered as in human plasma gelsolin (43), and segmental
boundaries are based on the structural definitions defined by the
gelsolin crystal (44). Actin, PIP2, and
Ca2+-binding segments are shown.
![]()
Gelsolin Structure-Function
TOP
INTRODUCTION
Overview about Severing,...
Gelsolin Functions in Vivo
Gelsolin Structure-Function
The Gelsolin Superfamily
Conclusions and Perspectives
REFERENCES
6
M.2 The isolated
N-half binds two actin molecules to sever and cap, even in the absence
of Ca2+. Because severing by full-length gelsolin requires
10
6 M Ca2+, the C-half must act
as a regulatory domain to inhibit severing by the N-half. In addition,
the C-half potentiates severing by the N-half, possibly through
cooperative binding to the filament (3).
-sheet that is sterically incompatible with actin binding (Fig.
2B). This explains why neither S1 nor S4 binds actin in the
absence of Ca2+. It also predicts that Ca2+
must induce major conformational changes in each half and in the
relation between the halves to accommodate actin binding.

View larger version (28K):
[in a new window]
Fig. 2.
Structural model of gelsolin in the absence
of Ca2+. A, full-length gelsolin;
B, gelsolin N- and C-halves. Figure was provided by R. Robinson. S1-S6, gelsolin segments 1-6; N and
C, N- and C-terminal half, respectively.
A recent cryoelectron microscopic study of a gelsolin construct missing
S1 attached to an actin filament (4) hints at the extent of the change
that is required. The reconstructed image shows that gelsolin S2-S6
binds to actin molecules in neighboring filament strands (via S2 and
S4). The distances between the S2 and S4 and the S1 and S2
actin-binding sites on the filament indicate that there must be large
scale conformational changes before S1, S2, and S4 can simultaneously
bind actin. The convoluted linker probably unwinds, and parts of the S1
or S2 core domain may have to unravel to extend the linker between S1
and S2 (as proposed in Refs. 44 and 47). A model for how this sequence
of events may occur is shown in Fig.
3.
|
Structural Basis for Ca2+ Regulation
The questions of how gelsolin is clamped in the inactive configuration under submicromolar Ca2+ conditions and how Ca2+ switches gelsolin on are clearly important because they pertain to proliferative and apoptotic signaling.
Multiple Ca2+-binding Sites--
Although gelsolin was
first identified as a Ca2+-regulated protein that binds two
Ca2+ with 10
6 M
Kd (48), subsequent studies find that gelsolin
interaction with Ca2+ is considerably more complex.
Isolated gelsolin domains have at least three Ca2+-binding
sites, with submicromolar and micromolar Kd values
(49). On binding actin, intermolecular and intramolecular Ca2+-binding sites are created (46,
50),3 so gelsolin can
potentially bind even more Ca2+ ions. Paradoxically, a
recent study finds that gelsolin binds only two Ca2+ ions
in the presence of actin, and they bind cooperatively (52). The
challenge will be to determine which of the currently identified Ca2+-binding sites are physiologically relevant and how
their occupancy alters gelsolin conformation.
At 37 °C, half-maximal severing is observed at 2 × 10
6 M Ca2+,2 which is
well within the physiological range encountered during surface receptor
stimulation. A small decrease in pH also reduces the Ca2+
requirement for severing significantly (53-55), suggesting that gelsolin can integrate these signals to generate fine-tuned responses in cells.
The C-half Talks to the N-half through the Tail Latch Mechanism-- Biochemical and physical studies indicate that Ca2+ opens up gelsolin by inducing a conformational change in the C-half to expose actin-binding sites on the N-half. The gelsolin/EGTA crystal structure shows that the C terminus of gelsolin has a tail extension that contains an unstructured strand capped with a short terminal helix (Fig. 1). The tail helix is in close contact with the actin binding helix of S2 (Fig. 2A) and may act as a latch to inhibit actin binding by the N-half in the absence of Ca2+. This is called the tail latch hypothesis.
The importance of the S6 tail in Ca2+ regulation is now
supported by deletion studies. Deletion of the tail helix decreases the
Ca2+ concentration for half-maximal activation of severing
from 2 × 10
6 M to 10
7
M,2 whereas deletion of the entire tail
abolishes the Ca2+ requirement for severing altogether
(57).2 Furthermore, tail helix deletion abolishes the
change in intrinsic tryptophan fluorescence observed at
10
6 M Ca2+ but not that at
submicromolar Ca2+ (53, 56).2 Therefore, the
tail latch is the major switch that releases the final constraint on
the N-half to initiate the severing cascade.
Gelsolin is unique among the gelsolin family proteins (see "The Gelsolin Superfamily") in relegating Ca2+ regulation of its N-half to the C-half through its tail. It may have evolved the unique tail latch mechanism to achieve stringent regulation of severing and capping and to permit dispensing with Ca2+ regulation entirely during apoptosis simply by cleaving the severing half from the regulatory half.
Ca2+ Activation of the Gelsolin C-half--
S4-S6 has
remained a black box for many years, even though it is the primary
Ca2+-activated switch for gelsolin. The Ca2+
activation model can now be refined considerably because a crystal structure of the C-half complexed with actin and Ca2+ has
just become available.3 As discussed above, in the absence
of Ca2+, S4 and S6 are melded together into an extended
-sheet (44) (Fig. 2B). In the presence of
Ca2+, the
-sheet is broken; S4 and S6 are completely
separated along their interface. S6 swings away from S4 and forms new
contacts with S5. Actin inserts into the space vacated by S6 and
creates an intermolecular Ca2+-binding site coordinated by
S4 and actin. These results confirm that that there are large scale
domain rearrangements during Ca2+ activation.
Structural Basis for PIP2 Regulation
Although there is ample evidence for reversible gelsolin-actin association in cells (reviewed in Ref. 1), gelsolin uncapping after severing cannot be achieved simply by reducing Ca2+. This is because a Ca2+ molecule is trapped between gelsolin S1 and actin, and it is inaccessible to EGTA (46). Phosphoinositides, particularly PIP2 (16, 58), are the only known agents that inhibit gelsolin severing and dissociate gelsolin from actin in vitro (59).
Gelsolin binds PIP2 with micromolar affinity (55). Binding is enhanced by Ca2+ and by low pH (55). Gelsolin prefers PIP2 to phosphatidylinositol-3,4,5-P3 (58, 60, 61) and does not bind inositol trisphosphate (17). Therefore, gelsolin binding is stereoselective and enhanced by the diacylglycerol chain. This requirement is unlike the situation with many pleckstrin homology proteins, which bind phosphoinositides and the equivalent inositol phosphates with similar affinity (62).
Gelsolin can simultaneously bind between one and three PIP2 molecules within lipid vesicles, and binding is highly dependent on the physical characteristics of the bilayer (63). Therefore, gelsolin regulation by PIP2 does not depend simply on the absolute PIP2 mass but is rather dictated by a complex relation between lipid bilayer composition and geometry. This, together with the ability of gelsolin to change its affinity for PIP2 in response to Ca2+ and pH (55) and to induce changes in PIP2 packing within the membrane (37), hints at the large number of signals that are sensed and integrated by gelsolin to carry out its functions. In addition, we are just beginning to appreciate the active role gelsolin may have in modulating phosphoinositide signaling (see "Effects of Gelsolin Overexpression on Cell Motility and Signaling").
PIP2 inhibits the gelsolin N-half, and the N-half
PIP2 binding sequences are mapped to a common flat,
solvent-exposed surface in the linker between S1-S2 and the beginning
of S2 in the gelsolin/EGTA crystal (Fig. 1). These sites have an acidic
amino acid consensus that does not resemble the pleckstrin homology
domain (64, 65). PIP2 induces a conformational change (55,
66) that may interfere with the local rearrangements required to permit
S2 and S1 to bind two actin molecules simultaneously (Fig. 3).
Structural information about gelsolin complexed with PIP2
will be required to determine whether this is how PIP2
inhibits gelsolin and if PIP2 binds to other gelsolin
domains as well.
| |
The Gelsolin Superfamily |
|---|
|
|
|---|
Many members of the gelsolin family that have three or six gelsolin repeats have been identified (reviewed in Refs. 1 and 2). They have distinct as well as overlapping patterns of tissue expression, which is consistent with specialized function (67). Except for gelsolin, Ca2+ regulation and actin binding are not segregated into the two halves of the molecule. For example, villin, a six-domain protein, has a Ca2+-dependent N-half (68), and CapG, a three-domain protein, has built-in Ca2+ regulation in its actin-binding segment (69).
Novel members with long N-terminal extensions have also been
discovered. For example, flightless I has an N-terminal extension of 16 tandem leucine-rich repeats (70), which can potentially mediate
heterologous protein-protein interactions. Its binding partners include
a family of novel proteins with coiled coil repeats (71, 72) and
possibly Ras (73). Through these interactions, flightless I may link
the actin cytoskeleton to intracellular and membrane structures to
integrate signaling responses.
| |
Conclusions and Perspectives |
|---|
|
|
|---|
This review has focused on the intracellular functions of gelsolin
and emphasizes progress made to obtain a mechanistic model of how
gelsolin regulates the actin cytoskeleton in response to Ca2+ and phosphoinositide signaling. With a clear
understanding of how actin regulatory proteins work individually, we
are now poised to delineate how they cooperate to orchestrate actin
dynamics within living cells. Some progress has already been made. One study shows that gelsolin and capping protein coordinately cap barbed
ends during platelet activation (73). Another study finds that
filaments capped by gelsolin and Arp2/3 at the barbed and pointed ends,
respectively, can still undergo rapid turnover in the presence of
ADF/cofilin, and new uncapped barbed ends are generated (51).
Therefore, gelsolin severing and capping can theoretically promote
de novo nucleation by Arp2/3 by increasing the number of
pointed filament ends and increasing the actin monomer pool (45). These
findings extend the scope of the involvement of gelsolin in regulating
actin dynamics.
| |
FOOTNOTES |
|---|
* This minireview will be reprinted in the 1999 Minireview Compendium, which will be available in December, 1999. This is the second article of four in the "Proteins That Regulate Dynamic Actin Remodeling in Response to Membrane Signaling Minireview Series." This work was supported by National Institutes of Health Grant GM51112 and Robert A. Welch Foundation Grant I-1200.
2 K.-M. Lin, M. Mejillano, and H. L. Yin, submitted for publication.
3 R. C. Robinson, M. Mejillano, V. Le, L. D. Burtnick, H. L. Yin, and S. Choe, submitted for publication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PIP2, polyphosphoinositide 4,5-bisphosphate; PIP5KI, phosphatidylinositol 5-kinase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Liu, Y. T., Rozelle, A. L., and Yin, H. L. (1998) in G Proteins, Cytoskeleton and Cancer (Maruta, H. , and Kohama, K., eds) , pp. 19-35, R. G. Landes Company, Austin, TX |
| 2. | Kwiatkowski, D. J. (1999) Curr. Opin. Cell Biol. 11, 103-108[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Selden, L. A.,
Kinosian, H. J.,
Newman, J.,
Lincoln, B.,
Hurwitz, C.,
Gershman, L. C.,
and Estes, J. E.
(1998)
Biophys. J.
75,
3101-3109 |
| 4. |
McGough, A.,
Chiu, W.,
and Way, M.
(1998)
Biophys. J.
74,
764-772 |
| 5. |
Hartwig, J. H.
(1992)
J. Cell Biol.
118,
1421-1442 |
| 6. | Witke, W., Sharpe, A. H., Hartwig, J. H., Azuma, T., Stossel, T. P., and Kwiatkowski, D. J. (1995) Cell 81, 41-51[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Azuma, T., Witke, W., Stossel, T. P., Hartwig, J. H., and Kwiatkowski, D. J. (1998) EMBO J. 17, 1362-1370[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Lu, M.,
Witke, W.,
Kwiatkowski, D. J.,
and Kosik, K. S.
(1997)
J. Cell Biol.
138,
1279-1287 |
| 9. | Endres, M., Fink, K., Zhu, J., Stagliano, N. E., Bondala, V., Geddes, J. W., Azuma, T., Mattson, M. P., Kwiatkowski, D. J., and Moscowitz, M. A. (1999) J. Clin. Invest. 10, 161-178 |
| 10. |
Arcaro, A.
(1998)
J. Biol. Chem.
273,
805-813 |
| 11. | Fruman, D. A., Meyers, R. E., and Cantley, L. C. (1998) Annu. Rev. Biochem. 67, 481-507[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Anderson, R. A.,
Boronenkov, I. V.,
Doughman, S. D.,
Kunz, J.,
and Loijens, J. C.
(1999)
J. Biol. Chem.
274,
9907-9910 |
| 13. |
Tolias, K. F.,
Cantley, L. C.,
and Carpenter, C. L.
(1995)
J. Biol. Chem.
270,
17656-17659 |
| 14. | Chong, L. D., Traynor-Kaplan, A., Bokoch, G. M., and Schwartz, M. A. (1994) Cell 79, 507-513[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Toker, A. (1998) Curr. Opin. Cell Biol. 10, 254-261[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Janmey, P. A., and Stossel, T. P. (1987) Nature 325, 362-364[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Lassing, I., and Lindberg, U. (1985) Nature 314, 472-474[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Schafer, D. A.,
Jennings, P. B.,
and Cooper, J. A.
(1996)
J. Cell Biol.
135,
169-179 |
| 19. |
Yonezawa, N.,
Nishida, E.,
Iida, K.,
Yahara, I.,
and Sakai, H.
(1990)
J. Biol. Chem.
265,
8382-8386 |
| 20. | Fukami, K., Furuhashi, K., Inagaki, M., Endo, T., Hatano, S., and Takenawa, T. (1992) Nature 359, 150-152[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Gilmore, A. P., and Burridge, K. (1996) Nature 381, 531-535[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Hirao, M.,
Sato, N.,
Kondo, T.,
Yonemura, S.,
Monden, M.,
Sasaki, T.,
Takai, Y.,
and Tsukita, S.
(1996)
J. Cell Biol.
135,
37-51 |
| 23. | Miki, H., Miura, K., and Takenawa, T. (1996) EMBO J. 15, 5326-5335[Medline] [Order article via Infotrieve] |
| 24. |
Higgs, H. N.,
and Pollard, T. D.
(1999)
J. Biol. Chem.
274,
32531-32534 |
| 25. |
Tsukita, S.,
and Yonemura, S.
(1999)
J. Biol. Chem.
274,
34507-34510 |
| 26. |
Carlier, M.-F.,
Ressad, F.,
and Pantaloni, D.
(1999)
J. Biol. Chem.
274,
33827-33830 |
| 27. |
Shibasaki, Y.,
Ishihara, H.,
Kizuki, N.,
Asano, T.,
Oka, Y.,
and Yazaki, Y.
(1997)
J. Biol. Chem.
272,
7578-7581 |
| 28. |
Schafer, D. A.,
Welch, M. D.,
Machesky, L. M.,
Bridgman, P. C.,
Meyer, S. M.,
and Cooper, J. A.
(1998)
J. Cell Biol.
143,
1919-1930 |
| 29. | Sakisaka, T., Itoh, T., Miura, K., and Takenawa, T. (1997) Mol. Cell. Biol. 17, 3841-3849[Abstract] |
| 30. | Hartwig, J. H., Bokoch, G. M., Carpenter, C. L., Janmey, P. A., Taylor, L. A., Toker, A., and Stossel, T. P. (1995) Cell 82, 643-653[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Zigmond, S. H.,
Joyce, M.,
Borleis, J.,
Bokoch, G. M.,
and Devreotes, P. N.
(1997)
J. Cell Biol.
138,
363-374 |
| 32. | Rohatgi, R., Ma, L., Miki, H., Lopez, M., Kirchhausen, T., Takenawa, T., and Kirschner, M. W. (1999) Cell 97, 221-231[CrossRef][Medline] [Order article via Infotrieve] |
| 33. |
Cunningham, C. C.,
Stossel, T. P.,
and Kwiatkowski, D. J.
(1991)
Science
251,
1233-1236 |
| 34. |
Sun, H.-Q.,
Lin, K.-M.,
and Yin, H. L.
(1997)
J. Cell Biol.
138,
811-820 |
| 35. |
Sun, H.-Q.,
Kwiatkowska, K.,
Wooten, D. C.,
and Yin, H. L.
(1995)
J. Cell Biol.
129,
147-156 |
| 36. | Hug, C., Jay, P. Y., Reddy, I., McNally, J. G., Bridgman, P. C., Elson, E. L., and Cooper, J. A. (1995) Cell 81, 591-600[CrossRef][Medline] [Order article via Infotrieve] |
| 37. |
Flanagan, L. A.,
Cunningham, C. C.,
Chen, J.,
Prestwich, G. D.,
Kosik, K. S.,
and Janmey, P. A.
(1997)
Biophys. J.
73,
1440-1447 |
| 38. | De Corte, V., Gettesmans, J., and Vandekerckhove, J. (1997) FEBS Lett. 401, 191-196[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
Kothakota, S.,
Azuma, T.,
Reinhard, C.,
Klippel, A.,
Tang, J.,
Chu, K.,
McGarry, T. J.,
Kirschner, M. W.,
Koths, K.,
Kwiatkowski, D. J.,
and Williams, L. T.
(1997)
Science
278,
294-298 |
| 40. |
Kamada, S.,
Kusano, H.,
Fujita, H.,
Ohtsu, M.,
Koya, R. C.,
Kuzumaki, N.,
and Tsujimoto, Y.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
8532-8537 |
| 41. | Dong, Y., Asch, H. L., Medina, D., Ip, M., Guzman, R., and Asch, B. B. (1999) Int. J. Cancer 81, 930-938[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Fujita, H., Laham, L. E., Janmey, P. A., Kwiatkowski, D. J., Stossel, T. P., Banno, Y., Nozawa, Y., Mllauer, L., Ishizaki, A., and Kuzumaki, N. (1995) Eur. J. Biochem. 229, 615-620[Medline] [Order article via Infotrieve] |
| 43. | Kwiatkowski, D. P., Stossel, T. P., Orkin, S. H., Mole, J. E., Colten, H. R., and Yin, H. L. (1986) Nature 323, 455-458[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Burtnick, L. D., Koepf, E. K., Grimes, J., Jones, E. Y., Stuart, D. I., McLaughlin, P. J., and Robinson, R. C. (1997) Cell 90, 661-670[CrossRef][Medline] [Order article via Infotrieve] |
| 45. |
Ressard, F.,
Didry, D.,
Egile, C.,
Pantaloni, D.,
and Carlier, M. F.
(1999)
J. Biol. Chem.
274,
20970-20977 |
| 46. | McLaughlin, P. J., Gooch, J. T., Mannherz, H.-G., and Weeds, A. G. A. (1993) Nature 364, 685-692[CrossRef][Medline] [Order article via Infotrieve] |
| 47. | McGough, A. (1998) Curr. Opin. Struct. Biol. 8, 166-176[CrossRef][Medline] [Order article via Infotrieve] |
| 48. |
Yin, H. L.,
Zaner, K. S.,
and Stossel, T. P.
(1980)
J. Biol. Chem.
255,
9494-9500 |
| 49. | Pope, B., Maciver, S., and Weeds, A. (1995) Biochemistry 34, 1583-1588[CrossRef][Medline] [Order article via Infotrieve] |
| 50. | Weeds, A. G., Gooch, J., McLaughlin, P., Pope, B., Bengtsdotter, M., and Karlsson, R. (1995) FEBS Lett. 360, 227-230[CrossRef][Medline] [Order article via Infotrieve] |
| 51. |
Barkalow, K.,
Witke, W.,
Kwiatkowski, D. J.,
and Hartwig, J. H.
(1996)
J. Cell Biol.
134,
389-399 |
| 52. | Gremm, D., and Wegner, A. (1999) Eur. J. Biochem. 262, 330-334[Medline] [Order article via Infotrieve] |
| 53. |
Kinosian, H. J.,
Newman, J.,
Lincoln, B.,
Selden, L. A.,
Gershman, L. C.,
and Estes, J. E.
(1998)
Biophys. J.
75,
3092-3100 |
| 54. |
Lamb, J. A.,
Allen, P. G.,
Tuan, B. Y.,
and Janmey, P. A.
(1993)
J. Biol. Chem.
268,
8999-9004 |
| 55. |
Lin, K.-M.,
Wenegieme, E. F.,
Lu, P.-J.,
Chen, C.-S.,
and Yin, H. L.
(1997)
J. Biol. Chem.
272,
20443-20450 |
| 56. | Pope, B. J., Gooch, J. T., and Weeds, A. G. (1997) Biochemistry 36, 15848-15855[CrossRef][Medline] [Order article via Infotrieve] |
| 57. |
Kwiatkowski, D. P.,
Janmey, P. A.,
and Yin, H. L.
(1989)
J. Cell Biol.
108,
1717-1726 |
| 58. | Lu, P. J., Wang, D. S., Lin, K. M., Yin, H. L., and Chen, C. S. (1999) Am. Chem. Soc. Symp. Ser. 718, 38-54 |
| 59. |
Janmey, P. A.,
Iida, K.,
Yin, H. L.,
and Stossel, T. P.
(1987)
J. Biol. Chem.
262,
12228-12236 |
| 60. | Lu, P. J., Hsu, A.-L., Wang, D.-S., Yan, H., Yin, H. L., and Chen, C. S. (1998) Biochemistry 37, 5738-5745[CrossRef][Medline] [Order article via Infotrieve] |
| 61. |
Hartwig, J. H.,
Kung, S.,
Kovacsovics, T.,
Janmey, P. A.,
Cantley, L. C.,
Stossel, T. P.,
and Toker, A.
(1996)
J. Biol. Chem.
271,
32986-32993 |
| 62. |
Rameh, L. E.,
Arvidsson, A.-K.,
Carraway, K. L., III,
Couvillon, A. D.,
Rathbun, G.,
Crompton, A.,
VanRenterghem, B.,
Czech, M. P.,
Ravichandran, K. S.,
Burakoff, S. J.,
Wang, D.-S.,
Chen, C.-S.,
and Cantley, L. C.
(1997)
J. Biol. Chem.
272,
22059-22066 |
| 63. | Tuominen, E. K. J., Holopainen, J. M., Chen, J., Prestwich, G. D., Bachiller, P. R., Kinnunen, P. K. J., and Janmey, P. A. (1999) Eur. J. Biochem. 262, 1-9[Medline] [Order article via Infotrieve] |
| 64. |
Janmey, P. A.,
Lamb, J.,
Allen, P. G.,
and Matsudaira, P. T.
(1992)
J. Biol. Chem.
267,
11818-11823 |
| 65. |
Yu, F.-X.,
Sun, H.-Q.,
Janmey, P. A.,
and Yin, H. L.
(1992)
J. Biol. Chem.
267,
14616-14621 |
| 66. |
Xian, W.,
Vegners, R.,
Janmey, P. A.,
and Braunlin, W. H.
(1995)
Biophys. J.
69,
2695-2702 |
| 67. | Arai, M., and Kwiatkowski, D. J. (1999) Dev. Dyn. 215, 297-307[CrossRef][Medline] [Order article via Infotrieve] |
| 68. | Matsudaira, P., Jakes, R., and Walker, J. E. (1985) Nature 315, 248-250[CrossRef][Medline] [Order article via Infotrieve] |
| 69. |
Yu, F.-X.,
Johnston, P. A.,
Sudhof, T. C.,
and Yin, H. L.
(1990)
Science
250,
1413-1415 |
| 70. |
Campbell, H. D.,
Schimansky, T.,
Claudianos, C.,
Ozsarac, N.,
Kasprzak, A. B.,
Cotsell, J. N.,
Young, I. G.,
de Couet, H. G.,
and Miklos, G. L. G.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
11386-11390 |
| 71. |
Liu, Y. T.,
and Yin, H. L.
(1998)
J. Biol. Chem.
273,
7920-7927 |
| 72. | Fong, K. S., and de Couet, H. G. (1999) Genomics 58, 146-157[CrossRef][Medline] [Order article via Infotrieve] |
| 73. | Goshima, M., Kariya, K., Yamawaki-Kataoka, Y., Okada, T., Shibatohge, M., Shima, F., Fujimoto, E., and Kataoka, T. (1999) Biochem. Biophys. Res. Commun. 257, 111-116[CrossRef][Medline] [Order article via Infotrieve] |
| 74. |
Yin, H. L.,
and Stull, J. T.
(1999)
J. Biol. Chem.
274,
32529-32530 |
This article has been cited by other articles:
![]() |
C.-L. Huang Complex roles of PIP2 in the regulation of ion channels and transporters Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1761 - F1765. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jia, M. Omelchenko, D. Garland, V. Vasiliou, J. Kanungo, M. Spencer, Y. Wolf, E. Koonin, and J. Piatigorsky Duplicated gelsolin family genes in zebrafish: a novel scinderin-like gene (scinla) encodes the major corneal crystallin FASEB J, October 1, 2007; 21(12): 3318 - 3328. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Deng, D. Xia, B. Fang, and H. Zhang The Flightless I Homolog, fli-1, Regulates Anterior/Posterior Polarity, Asymmetric Cell Division and Ovulation During Caenorhabditis elegans Development Genetics, October 1, 2007; 177(2): 847 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Q. P. Noguchi, N. Kanzaki, H. Ueno, K. Hirose, and T. Q. P. Uyeda A Novel System for Expressing Toxic Actin Mutants in Dictyostelium and Purification and Characterization of a Dominant Lethal Yeast Actin Mutant J. Biol. Chem., September 21, 2007; 282(38): 27721 - 27727. [Abstract] [Full Text] [PDF] |
||||
![]() |
Ashish, M. S. Paine, P. B. Perryman, L. Yang, H. L. Yin, and J. K. Krueger Global Structure Changes Associated with Ca2+ Activation of Full-length Human Plasma Gelsolin J. Biol. Chem., August 31, 2007; 282(35): 25884 - 25892. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xiang, X. Huang, T. Wang, Y. Zhang, Q. Liu, P. J. Hussey, and H. Ren ACTIN BINDING PROTEIN29 from Lilium Pollen Plays an Important Role in Dynamic Actin Remodeling PLANT CELL, June 1, 2007; 19(6): 1930 - 1946. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yermen, A. Tomas, and P. A. Halban Pro-Survival Role of Gelsolin in Mouse {beta}-Cells Diabetes, January 1, 2007; 56(1): 80 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Miano, X. Long, and K. Fujiwara Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus Am J Physiol Cell Physiol, January 1, 2007; 292(1): C70 - C81. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Song, X. Chen, H. Yamaguchi, G. Mouneimne, J. S. Condeelis, and R. J. Eddy Initiation of cofilin activity in response to EGF is uncoupled from cofilin phosphorylation and dephosphorylation in carcinoma cells J. Cell Sci., July 15, 2006; 119(14): 2871 - 2881. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sakurai and T. Utsumi Posttranslational N-Myristoylation Is Required for the Anti-apoptotic Activity of Human tGelsolin, the C-terminal Caspase Cleavage Product of Human Gelsolin J. Biol. Chem., May 19, 2006; 281(20): 14288 - 14295. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tomas, B. Yermen, L. Min, J. E. Pessin, and P. A. Halban Regulation of pancreatic {beta}-cell insulin secretion by actin cytoskeleton remodelling: role of gelsolin and cooperation with the MAPK signalling pathway J. Cell Sci., May 15, 2006; 119(10): 2156 - 2167. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Uruno, K. Remmert, and J. A. Hammer III CARMIL Is a Potent Capping Protein Antagonist: IDENTIFICATION OF A CONSERVED CARMIL DOMAIN THAT INHIBITS THE ACTIVITY OF CAPPING PROTEIN AND UNCAPS CAPPED ACTIN FILAMENTS J. Biol. Chem., April 14, 2006; 281(15): 10635 - 10650. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Ada-Nguema, H. Xenias, M. P. Sheetz, and P. J. Keely The small GTPase R-Ras regulates organization of actin and drives membrane protrusions through the activity of PLC{epsilon} J. Cell Sci., April 1, 2006; 119(7): 1307 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Apostolova, T. Christova, and D. M. Templeton Involvement of Gelsolin in Cadmium-Induced Disruption of the Mesangial Cell Cytoskeleton Toxicol. Sci., February 1, 2006; 89(2): 465 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Osborn, A. Rabodzey, C. F. Dewey Jr., and J. H. Hartwig Endothelial actin cytoskeleton remodeling during mechanostimulation with fluid shear stress Am J Physiol Cell Physiol, February 1, 2006; 290(2): C444 - C452. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Candiano, M. Bruschi, N. Pedemonte, E. Caci, S. Liberatori, L. Bini, C. Pellegrini, M. Vigano, B. J. O'Connor, T. H. Lee, et al. Gelsolin Secretion in Interleukin-4-treated Bronchial Epithelia and in Asthmatic Airways |